GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Regenerative Medical Technology Group RMTG · USD

Consumer Discretionary · US listing · 🇺🇸 United States

Compare

0.03

0.00%

Close of 5 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Regenerative Medical Technology Group

From its filings with the US Securities and Exchange Commission

SEC filings

Regenerative Medical Technology Group is based in Boca Raton, Florida. Its shares trade on OTC under the ticker RMTG. The SEC classifies its business as retail-retail stores, nec. In the fiscal year to 31 December 2025, it reported revenue of $5.1m and a net loss of $7.8m. At that date it held total assets of $4.5m and shareholders' equity of −$34.7m.

Read the filing on SEC.gov ↗

Company facts

Sector
Consumer Discretionary
Industry
Specialty Retail
Listed since
28 Dec 2001
Employees
1
Head office
433 PLAZA REAL SUITE 275, BOCA RATON, FL, 33432
Classification
Retail-Retail Stores, NEC
Filer status
Non-accelerated filer<br>Smaller reporting company

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Regenerative Medical Technology Group Inc specializes in stem cell therapy and clinical applications globally.
  • Meso Numismatics, Inc. provides stem cell research and physician training through ISCCA network.
  • The company's flagship operation in Istanbul uses exosomes and stem cells for disease treatment.

Weaknesses

  • The company employs only 1 full-time employee, limiting operational capacity.
  • Regenerative Medical Technology Group Inc has a single location in Boca Raton, Florida.
  • The company went public on 28 December 2001, indicating limited market presence.

Opportunities

  • Expanding stem cell therapy applications in the Consumer Discretionary sector.
  • Growing demand for regenerative medicine in the Health Care industry.
  • ISCCA network can expand globally to new markets and segments.

Threats

  • Regenerative Medical Technology Group Inc faces competition from established healthcare providers.
  • The company's single employee count may hinder growth and innovation.
  • Stem cell therapy regulations could restrict commercialization efforts.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.